New Zealand private equity firm Oriens Capital has hit the NZ$80 million ($56 million) target for its second fund and is now seeking NZ$20 million in oversubscriptions.
Oriens’ first fund closed at NZ$50.6 million in late 2016, comfortably beating the NZ$30 million target. Most of the investors in that fund are also backing Fund II, including Quayide Holdings, a regional...
China has imposed severe restrictions on private tutoring that appear to undermine the commercial viability of companies in the space, potentially making private equity investment unviable.
Best & Less Group (BLG), an Australian baby, kids and womenswear retailer, has raised A$60 million ($44 million) through a domestic IPO, facilitating a partial exit for majority owner Allegro Funds Group.
TransThera, a China-based drug developer, has raised $100 million in Series D funding led by CPE and China Structural Reform Fund.
B Capital Group has hired Sheila Patel, formerly the Singapore-based chairman of Goldman Sachs Asset Management, as a vice president amid a concerted Asian expansion drive.